Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Connor

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Pediatric Research|June 1, 1972
The oxidation of glycine and propionic acid in propionic acidemia with ketotic hyperglycinemiaT Ando, W L Nyhan, J D Connor, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1978
Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitorH J Doller, J D Connor, D R Lock, et al.
The American Journal of Medicine|July 20, 1982
Metabolic fate of radioactive acyclovir in humansP de Miranda, S S Good, H C Krasny, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndromeR B Roberts, O L Laskin, J Laurence, et al.
Journal of Medical Virology|January 1, 1993
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysisJ C Huff, J L Drucker, A Clemmer, et al.
The Journal of Infectious Diseases|May 1, 1983
Adenovirus type 7b in a children's hospitalR C Straube, M A Thompson, R B Van Dyke, et al.
Pediatrics|December 1, 1983
Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapyR J Whitley, A Yeager, P Kartus, et al.
The Journal of Infectious Diseases|May 1, 1989
The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic markerS A Spector, C Kennedy, J A McCutchan, et al.
Clinical Pharmacology and Therapeutics|May 1, 1987
Ribavirin disposition in high-risk patients for acquired immunodeficiency syndromeO L Laskin, J A Longstreth, C C Hart, et al.
Research Communications in Molecular Pathology and Pharmacology|November 25, 2003
Plasma from rheumatoid patients taking low dose methotrexate enhances platelet aggregationS A Saeed, A H Gilani, H Rasheed, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Pediatric Research|June 1, 1972
The oxidation of glycine and propionic acid in propionic acidemia with ketotic hyperglycinemiaT Ando, W L Nyhan, J D Connor, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1978
Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitorH J Doller, J D Connor, D R Lock, et al.
The American Journal of Medicine|July 20, 1982
Metabolic fate of radioactive acyclovir in humansP de Miranda, S S Good, H C Krasny, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndromeR B Roberts, O L Laskin, J Laurence, et al.
Journal of Medical Virology|January 1, 1993
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysisJ C Huff, J L Drucker, A Clemmer, et al.
The Journal of Infectious Diseases|May 1, 1983
Adenovirus type 7b in a children's hospitalR C Straube, M A Thompson, R B Van Dyke, et al.
Pediatrics|December 1, 1983
Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapyR J Whitley, A Yeager, P Kartus, et al.
The Journal of Infectious Diseases|May 1, 1989
The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic markerS A Spector, C Kennedy, J A McCutchan, et al.
Clinical Pharmacology and Therapeutics|May 1, 1987
Ribavirin disposition in high-risk patients for acquired immunodeficiency syndromeO L Laskin, J A Longstreth, C C Hart, et al.
Research Communications in Molecular Pathology and Pharmacology|November 25, 2003
Plasma from rheumatoid patients taking low dose methotrexate enhances platelet aggregationS A Saeed, A H Gilani, H Rasheed, et al.
Pageof 15